Skip to content

CAREGIVER: A Trial to Improve the Burden and Distress of Caring for Persons With Decompensated Cirrhosis

CAREGIVER: An Randomized Clinical Trial (RCT) to Improve the Burden and Distress of Caring for Persons With Decompensated Cirrhosis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04205396
Enrollment
87
Registered
2019-12-19
Start date
2020-02-10
Completion date
2022-03-22
Last updated
2022-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Caregivers

Keywords

cirrhosis, hepatic encephalopathy, ascites, varices, liver disease, resilience training, expressive writing

Brief summary

The goal of this study is to enroll caretakers of patients with decompensated cirrhosis to determine if written emotional disclosure or resilience training interventions reduce distress and burden among primary informal caregivers. Caretakers that meet eligibility will complete baseline assessments in person, or if necessary, over the phone and be randomized to be in one of three arms of this study. Materials specific to each study arm will be mailed to the caretakers home along with instructions. Overall, the study will take approximately 2 months and a qualitative interview will also be completed around 3-6 months post-baseline.

Interventions

Participants will write five stories (days 8, 11, 14, 17 and 20) about an assigned topic relating to their experiences as a caregiver of someone with advanced liver disease. Rules for the exercise will be provided in an instructions page. Additionally, baseline and outcome measures will be completed.

Participants will write three things that went well at the end of their day (before going to sleep), and what was their role in bringing them. These will be done about every three days (days 8, 11, 14, 17 and 20) for 2 weeks at home. Rules for the exercise will be provided in an instructions page. Additionally, baseline and outcome measures will be completed.

OTHERNo treatment

Participants will complete baseline and outcome assessments and no intervention will be conducted.

Sponsors

University of Michigan
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Primary informal caregiver for a patient with a clinical diagnosis of decompensated cirrhosis with either of the following three clinical criteria: 1. Child-Turcotte Pugh (CTP) Class A/B/C cirrhosis with an all cause hospitalization within the previous 30 days. 2. CTP Class B or C cirrhosis with one of the following within the prior 6 months from the date of enrollment: 1. Ascites (requiring paracentesis or diuretics) 2. Overt Hepatic Encephalopathy (requiring lactulose or rifaximin/flagyl/neomycin) 3. Spontaneous Bacterial Peritonitis (SBP) 4. Hepatic Hydrothorax (requiring diuretics or thoracentesis) 5. Variceal Bleed (with 1 or more recurrences) 3. Hepatocellular Carcinoma (HCC) 1. Any Barcelona Clinic Liver Cancer (BCLC) Stage with CTP Class B or C 2. BCLC Stage C or D with CTP Class A

Exclusion criteria

* Non-English speaking * Unable or unwilling to provide verbal consent * Severe cognitive impairment * Caregiver is participating in another interventional study * Caregiver has used a personal diary within the past 12 months

Design outcomes

Primary

MeasureTime frameDescription
Change in burden of caregivers measured using the Zarit Burden Interview (ZBI -12)At baseline and then at 4 week and 8 weeksThe short form of the ZBI is a validated short 12-item questionnaire measuring perceived burden associated with care giving. Participants rate each item on a 5-point scale ranging from 0 (never) to 4 (nearly always) the range of possible score is 0 (less burden) to 48 (more burden).

Secondary

MeasureTime frameDescription
Change in Visual Analogue Score (VAS)At baseline and then at 4 week and 8 weeksThe VAS is a measure of health related quality of life (HRQOL). It is a scale from 0 to 100 where 0 represents the worst imaginable health state and 100 represents the best imaginable health state.
Change in Distress Thermometer (DT)At baseline and then at 4 week and 8 weeksThis is a single-item self-report measure of distress. The DT is presented as a 10-point scale in a thermometer format and asks to rate how distressed one felt in the previous week from 0 (not distressed) to 10 (extremely distressed).
Change in Caregiver Captivity Index (CCI)At baseline and then at 4 week and 8 weeksA three-item self-report measure of how much (very much, somewhat, just a little, not at all) a caregiver feels like a captive, or being an unwilling or involuntary incumbent of a caregiver role. Scored on a scale of 4-12 with higher scores being worse

Other

MeasureTime frameDescription
Rate of Healthcare utilization by care recipient6 months after randomizationNumber of hospitalizations, number of unscheduled outpatient visits, number of ER visits

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026